LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 116c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($1.16). Revenue for the quarter came in at $1.59 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings